Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers
Fierce Pharma
Thu, 08/26/21 - 08:52 pm
Tags:
Gilead Sciences, Kite Pharma, CAR-T, patents, Bristol Myers Squibb
New fault lines emerge in CAR-T therapy
EP Vantage
Tue, 08/24/21 - 10:43 am
Tags:
CAR-T, Novartis, Kymriah, Bristol Myers Squibb, Beyanzi, Gilead Sciences, Yescarta, clinical trials
Oral Remdesivir Could Lower COVID Hospitalizations, Preclinical Study Says
BioSpace
Mon, 08/23/21 - 11:29 pm
Tags:
Gilead Sciences, remdesivir, COVID-19
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Tags:
Gilead Sciences, Regeneron, AstraZeneca, FDA, PROs, oncology, clinical trials, patient-reported outcomes
Gilead cements its long-acting HIV ambitions
EP Vantage
Fri, 08/13/21 - 10:51 am
Tags:
Gilead Sciences, HIV, lenacapavir, clinical trials
Gilead latest biopharma company to require U.S. workers receive COVID-19 vaccine
Yahoo/Reuters
Tue, 08/10/21 - 10:44 am
Tags:
Gilead Sciences, Pfizer, COVID-19, vaccines
Gilead Foundation bounces back with a bang—$200M in the bank and ambitious goals
Fierce Pharma
Fri, 08/6/21 - 11:09 am
Tags:
Gilead Sciences, Gilead Foundation, non-profits
With an assist from AstraZeneca, the salvage crew at Sierra bets another $216M they can resurrect an old Gilead JAK drug
Endpoints
Fri, 08/6/21 - 11:07 am
Tags:
Gilead Sciences, AstraZeneca, Sierra Oncology, AZD5153, oncology
Gilead's Kite, Appia Bio to Collaborate on Allogeneic Cell Therapies for Cancer
Marketwatch
Thu, 08/5/21 - 11:04 am
Tags:
Gilead Sciences, Kite Pharma, Appia Bio, cancer, cell therapy
Drugs facing the most patent expirations this year
Drug Patent Watch
Sun, 08/1/21 - 11:46 pm
Tags:
patents, Novartis, Sunovion, Allergan, Bayer, Gilead Sciences
Gilead Earnings Top Views; Biotech Giant Narrows Guidance
Investors Business Daily
Fri, 07/30/21 - 11:03 am
Tags:
Gilead Sciences, earnings
3 Biotechs That Could Make Big Acquisitions This Year
Motley Fool
Thu, 07/22/21 - 11:10 am
Tags:
M&A, AbbVie, Vertex Pharmaceuticals, Gilead Sciences
BioNTech returns to cancer roots with deal for Gilead cell therapy factory
BioPharma Dive
Mon, 07/19/21 - 11:10 pm
Tags:
BioNTech, cancer, Gilead Sciences, Kite Pharma, cell therapy
Gilead's Veklury shows 'no antiviral effects' against COVID-19 in small WHO study
Fierce Pharma
Mon, 07/12/21 - 11:38 pm
Tags:
Veklury, Gilead Sciences, COVID-19
Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal
BioPharma Dive
Wed, 06/30/21 - 12:11 am
Tags:
antivirals, COVID-19, Gilead Sciences, Foresite, Pardes Biosciences
Gilead challenges ViiV in resistant HIV, filing twice-yearly therapy
Pharmaforum
Tue, 06/29/21 - 10:52 am
Tags:
Gilead Sciences, HIV, ViiV Healthcare, FDA, lenacapavir, Rukobia
Biopharma M&A set for a strong H2 despite political noise—and Biogen and Gilead look like buyers: analysts
Fierce Pharma
Mon, 06/28/21 - 11:54 am
Tags:
M&A, Joe Biden, Biogen, Gilead Sciences, oncology, gene therapy
Gilead's Kite earns second-line win for CAR-T Yescarta, setting up a battle over earlier blood cancer patients
Endpoints
Mon, 06/28/21 - 10:51 am
Tags:
Gilead Sciences, Kite Pharma, Yescarta, relapsed or refractory diffuse large B-cell lymphoma, CAR-T
Gilead preps filing for hepatitis D therapy Hepcludex in US
Pharmaforum
Fri, 06/25/21 - 11:03 am
Tags:
Gilead Sciences, Hepcludex, hepatitis D
Real-world remdesivir data add to body of evidence for Gilead Sciences Covid-19 drug
MedCity News
Tue, 06/22/21 - 11:09 am
Tags:
Gilead Sciences, remdesivir, COVID-19, real world data, real world evidence, RWE

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.